Chris Pieczonka, MD

Chris Pieczonka, MD, Chief Executive Officer and Director of Clinical Research, Associated Medical Professionals

Articles by Chris Pieczonka, MD

In the final segment of the roundtable, the panel debates the real-world integration of new therapies into everyday practice.

In part five of this NMIBC roundtable, the panelists discuss integrating new therapies such as TAR-200 into clinical practice

Part four of this roundtable series examines the SunRISe-1 trial results for high-risk NMIBC.

The panelists discuss advancements in NMIBC treatment in part three of this roundtable, including pembrolizumab and TAR-200.

Part two of this roundtable explores intravesical and systemic therapies, and the importance of accurate risk stratification.

The first part of this roundtable focuses on recent trial data, the role of TUR quality, and precision medicine for NMIBC.